Bone marrow-derived mesenchymal stem cells and the tumor microenvironment

Over the last decade, there has been a growing interest in the role of mesenchymal stem cells (MSC) in cancer progression. These cells have the potential to give rise to a variety of mesenchymal cells like osteoblasts, chondrocytes, adipocytes, fibroblasts, and muscle cells. In contrast to their hem...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer and metastasis reviews Jg. 29; H. 2; S. 249 - 261
Hauptverfasser: Bergfeld, Scott A., DeClerck, Yves A.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Boston Springer US 01.06.2010
Springer
Springer Nature B.V
Schlagworte:
Animals
Biomedical and Life Sciences
Biomedicine
Bone Marrow Cells - physiology
Cancer Research
Development and progression
Humans
Mesenchymal Stromal Cells - physiology
Metastasis
Neoplasm Invasiveness - pathology
Neoplasm Metastasis - pathology
Neoplasms - pathology
Oncology
Stem cells
Bone marrow
Metastasis
Tumor microenvironment
Mesenchymal stem cells
ISSN:0167-7659, 1573-7233, 1573-7233
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Over the last decade, there has been a growing interest in the role of mesenchymal stem cells (MSC) in cancer progression. These cells have the potential to give rise to a variety of mesenchymal cells like osteoblasts, chondrocytes, adipocytes, fibroblasts, and muscle cells. In contrast to their hematopoetic counterparts, MSC are not as clearly defined, which makes the interpretation of their role in cancer progression more complex. However, the nature of the relationship between MSC and tumor cells appears dual. Primary and metastatic tumors attract MSC in their microenvironment where they become tumor-associated fibroblasts, affect tumor cell survival and angiogenesis, and have an immunomodulatory function, and vice versa in the bone marrow MSC attract tumor cells and contribute to a microenvironment that promotes osteolysis, tumor growth, survival, and drug resistance. Whether MSC are pro- or anti-tumorigenic is a subject of controversial reports that is in part explained by the complexity of their interaction with tumor cells and the large range of cytokines and growth factors they produce. The study of these interactions is a fertile ground of investigation that—as already demonstrated in the case of myeloma—should lead to novel therapeutic approaches in cancer. In this article, the biology and role of MSC in cancer is reviewed with a primary focus on bone marrow-derived MSC.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0167-7659
1573-7233
1573-7233
DOI:10.1007/s10555-010-9222-7